Management's Discussion and Analysis of Financial Condition and Results of Operations
Caution Regarding Forward-Looking Information
This Quarterly Report on Form 10-Q, including, without limitation, statements containing the words "believes", "anticipates", "expects" and words of similar import, constitute forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company, or industry results, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements.
Such factors include, among others, the following: international, national and local general economic and market conditions: demographic changes; the ability of the Company to sustain, manage or forecast its growth; the ability of the Company to successfully make and integrate acquisitions; existing government regulations and changes in, or the failure to comply with, government regulations; adverse publicity; competition; fluctuations and difficulty in forecasting operating results; changes in business strategy or development plans; business disruptions; the ability to attract and retain qualified personnel; and other factors referenced in this and previous filings.
Given these uncertainties, readers of this Form 10-Q and investors are cautioned not to place undue reliance on such forward-looking statements. The Company disclaims any obligation to update any such factors or to publicly announce the result of any revisions to any of the forward-looking statements contained herein to reflect future events or developments.
Overview of Our Business
For future business development and medical applications, VitaSpring cooperates with affiliated companies to support the mass production and commercialization of X.msc-related medical projects. Some X.msc-based projects are researches and trials of Investment New Drugs and part of them are related to X.exosome, the critical material in the related skincare products. VitaSpring management also expect X.msc-related medical projects to implement in hospitals from a small scale in the future five years.
Recent Developments
On
Under new management, VitaSpring has completed the transition from patent
technology into the know-how in the mass-production process of the purifying and
culturing technology in the allogeneic mesenchymal stem cell production from the
maternal-part placenta. The subject know-how can effectively and steadily
culture more than 20 generations of sub-culture cells, which maintain the same
level of activity index and contain the magnification of one thousand exosomes
than other MSCs in terms of per ml. Accordingly, VitaSpring is able to build
stem cell bank regulated by
VitaSpring's research team has been awarded the 16th, 17 th, 18 th Taiwan
National Innovation Award certificates in 2019, 2020, and 2021 and joined the
regenerative medicine flagships of the
18 Business Plan
Through the development of cell medicine, we became a leading international business group in the fields of regenerative medicine applied to the innovative fields of medicine, preventive health care, beauty, and anti-aging. We do not sell products in a form for use by consumers although we may, in the future, develop products for use by consumers.
We have many unique advantages elevating us to be the best in the industry:
1. Discovery and successful isolation of special mesenchymal stem cells (X.msc)
2. Unlike typical MSCs, X.msc do not promote cancer and tumor growth, and is safe to use for the entire body
3. Homogeneous purification technology
4. Viability of X.msc is 1000 time that of the competitor
5. Able to proliferate and maintain stemness of stem cells to 25+ generations
6. Exclusive composition formula of culture medium
7. The exclusive formula of exosomes have a variety of applications
8. Extensive uses of X.msc
9. Immunomodulation and anti-inflammation effect
10. No ethical issues Available Information
We file with the
Our corporate headquarters are located at
Results of Operations for the Three months Ended
Revenue and cost of goods sold
For the Three months ended
Operating expenses
Total operating expenses for the quarter ended
Net Income
The net income for the quarter ended
Liquidity and Capital Resources and Cash Requirements
At
During the quarter ended
During the quarter ended
We cannot guarantee that we will manage to sell all the shares required. We will attempt to raise the necessary funds to proceed with all phases of our plan of operation. As of the date of this report, the current funds available to the Company will not be sufficient to continue maintaining a reporting status.
Our auditors have issued a "going concern" opinion, meaning that there is substantial doubt we can continue as an on-going business for the next twelve months unless we obtain additional capital. Our only sources for cash at this time are investments by others in this offering, selling our paper dung products and loans from our director. We must raise cash to implement our plan and stay in business.
Management believes that current trends toward lower capital investment in start-up companies pose the most significant challenge to the Company's success over the next year and in future years. Additionally, the Company will have to meet all the financial disclosure and reporting requirements associated with being a publicly reporting company. The Company's management will have to spend additional time on policies and procedures to make sure it is compliant with various regulatory requirements, especially that of Section 404 of the Sarbanes-Oxley Act of 2002. This additional corporate governance time required of management could limit the amount of time management has to implement is business plan and impede the speed of its operations.
19
Limited operating history; need for additional capital
There is no historical financial information about us upon which to base an evaluation of our performance. We are in a start-up stage of operations and have generated limited revenues since inception. We cannot guarantee that we will be successful in our business operations. Our business is subject to risks inherent in the establishment of a new business enterprise, including limited capital resources and possible cost overruns due to price and cost increases in services and products.
Off-Balance Sheet Arrangements
We do not maintain any off-balance sheet arrangements, transactions, obligations or other relationships with unconsolidated entities that would be expected to have a material current or future effect upon our financial condition or results of operations.
Going Concern
The Company has a retained earnings of
Recent Accounting Pronouncements
In
In
Management has considered all recent accounting pronouncements issued since and their potential effect on our financial statements. The Company's management believes that these recent pronouncements will not have a material effect on the Company's consolidated financial statements.
Other recent accounting pronouncements issued by the FASB, including its
20
© Edgar Online, source